Erlotinib therapy in non small cell lung cancer patients-survival of "poor prognosis patients"
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F09%3A00036397" target="_blank" >RIV/00216224:14110/09:00036397 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Erlotinib therapy in non small cell lung cancer patients-survival of "poor prognosis patients"
Original language description
"Poor prognosis" NSCLC patients were treated with erlotinib and their survival of evaluated. Erlotinib therapy in non small cell lung cancer patients-survival of "poor prognosis patients"
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FC - Pneumology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2009
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Thoracic Oncology
ISSN
1556-0864
e-ISSN
—
Volume of the periodical
4
Issue of the periodical within the volume
9
Country of publishing house
US - UNITED STATES
Number of pages
3
Pages from-to
—
UT code for WoS article
—
EID of the result in the Scopus database
—